Merck (MRK) Long-Term Investments (2009 - 2026)

Merck (MRK) has 18 years of Long-Term Investments data on file, last reported at $1.1 billion in Q1 2026.

• Quarterly Long-Term Investments rose 343.78% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 343.78% YoY) and the FY2025 annual result came in at $956.0 million, up 106.48% from the prior year.
• Long-Term Investments climbed to $1.1 billion in Q1 2026 per MRK's latest filing, from $956.0 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $1.3 billion in Q3 2023 and bottomed at $238.0 million in Q2 2022.
• The 5-year median for Long-Term Investments is $622.0 million (2023), against an average of $635.0 million.
• The widest annual swing landed in 2023, when Long-Term Investments slumped 75.17%; it then surged 343.78% in 2026.
• Tracing MRK's Long-Term Investments over 5 years: stood at $1.0 billion in 2022, then tumbled by 75.17% to $252.0 million in 2023, then surged by 83.73% to $463.0 million in 2024, then jumped by 106.48% to $956.0 million in 2025, then rose by 15.59% to $1.1 billion in 2026.
• Per Business Quant, the three latest MRK Long-Term Investments figures stand at $1.1 billion (Q1 2026), $956.0 million (Q4 2025), and $1.1 billion (Q3 2025).

Peer Comparison